Article Details

AstraZeneca selects Reify platform to accelerate clinical development

Retrieved on: 2021-04-21 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca selects Reify platform to accelerate clinical development. View article details on hiswai:

Excerpt

AstraZeneca has selected Reify Health's patient enrolment management platform, StudyTeam, to accelerate clinical development across its portfolio of ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up